Back
Sarepta Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66
SRPT
Sarepta Therapeutics
Last Price:
$61.54
Seasonality Move:
13.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.3 | Buy |
| 20-day SMA: | 57.17 | Buy |
| 50-day SMA: | 80.89 | Sell |
| 200-day SMA: | 116.12 | Sell |
| 8-day EMA: | 58.3 | Buy |
| 20-day EMA: | 61.18 | Sell |
| 50-day EMA: | 76.52 | Sell |
| 200-day EMA: | 105.84 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.02 | Sell |
| Relative Strength Index (14 RSI): | 43.26 | Sell |
| Chaikin Money Flow: | -671213 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.37 - 68.59) | Sell |
| Bollinger Bands (100): | (75.16 - 127.4) | Sell |
Sarepta Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 60.44 while SRPT 8-day simple moving average is 57.30, which is a Buy signal.
-
The stock price of SRPT is 60.44 while Sarepta Therapeutics 20-day SMA is 57.17, which makes it a Buy.
-
Sarepta Therapeutics 50-day simple moving average is 80.89 while SRPT share price is 60.44, making it a Sell technically.
-
SRPT stock price is 60.44 and Sarepta Therapeutics 200-day simple moving average is 116.12, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Buy
66
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a BuyThe current Sarepta Therapeutics [SRPT] share price is $60.44. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
5.9B
Price in USD:
60.44
Share Volume:
1.3M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
48.01
Buy
66
Sarepta Therapeutics (SRPT)
is a Buy
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 60.44 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is not overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 60.44 while SRPT 8-day exponential moving average is 58.30, which is a Buy signal.
-
The stock price of SRPT is 60.44 while Sarepta Therapeutics 20-day EMA is 61.18, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 76.52 while SRPT share price is 60.44, making it a Sell technically.
-
SRPT stock price is 60.44 and Sarepta Therapeutics 200-day simple moving average is 105.84, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -6.02, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 43.26, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (52.37 - 68.59), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (75.16 - 127.4), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.